Physostigmine in Anticholinergic Poisoning: An Old Antidote With Resurgence.

anticholinergic delirium anticholinergic overdose physostigmine

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
28 Nov 2020
Historique:
entrez: 6 1 2021
pubmed: 7 1 2021
medline: 7 1 2021
Statut: epublish

Résumé

Physostigmine is a cholinesterase inhibitor used therapeutically in patients with anticholinergic delirium that is so severe that intubation may be required for airway protection. Given that a wide variety of medications have anticholinergic properties, and the current standard of care is typically a central nervous system depressant, hospitalizations are often lengthy and normally require a critical-care level of attention. Despite this, physostigmine is often underutilized and poorly understood in the clinical setting. We report a case of a 43-year-old female who presented to the emergency department one hour after ingesting approximately 150 tablets of diphenhydramine in a suicide attempt. She was treated with benzodiazepines with minimal success, and airway protection became imminent as her mentation continued to decline. Through the use of physostigmine, we were able to save this patient from endotracheal intubation and the potential complications of mechanical ventilation.

Identifiants

pubmed: 33403170
doi: 10.7759/cureus.11739
pmc: PMC7773307
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e11739

Informations de copyright

Copyright © 2020, Blackstone et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Ann Emerg Med. 1980 Nov;9(11):588-90
pubmed: 7001962
J Med Toxicol. 2010 Dec;6(4):386-92
pubmed: 20405266
Ann Pharmacother. 2019 Oct;53(10):1026-1032
pubmed: 31023063
Ann Emerg Med. 2000 Apr;35(4):374-81
pubmed: 10736125
Br J Clin Pharmacol. 2016 Mar;81(3):516-24
pubmed: 26589572
J Med Toxicol. 2019 Jul;15(3):184-191
pubmed: 30747326
Clin Toxicol (Phila). 2018 Feb;56(2):101-107
pubmed: 28703024

Auteurs

Nicholas G Blackstone (NG)

Internal Medicine, University of Arizona College of Medicine - Tucson, Tucson, USA.

April Olson (A)

Internal Medicine, University of Arizona College of Medicine - Tucson, Tucson, USA.

Bujji Ainapurapu (B)

Internal Medicine, University of Arizona College of Medicine - Tucson, Tucson, USA.

Classifications MeSH